CST4 and breast cancer: To that respect, the targeted delivery of cathepsin inhibitors has also been followed by Kos et al. by adsorbing anti-cytokeratin antibodies onto their cystatin-loaded PLGA nanosphere systems to enhance delivery to breast cancer cells in vitro [106,107].